Tag: FSMA
FSMA study: riskier products carry higher costs
Europe | Regulations & Legal
18 Oct 2023 by SRP News
Research by the Belgian regulator found that non-capital protected products, those denominated in foreign currencies and structures linked to indices have higher costs associated to them.
FSMA bans five products, targets crypto investments
Europe | Regulations & Legal
27 Jun 2023 by SRP News
The Belgian regulator deemed five structured products linked to proprietary indices ‘too complex’ for retail investors in 2021.
Belgium Q1 2023: record tickets, fixed income and capital protection
Europe | Products
10 May 2023 by Marc Wolterink
Volumes reached an eight-year high in the Belgian market which recorded the best-selling product of all time during the quarter.
Belgian insurer partners with Goldman, tracks ESG benchmark
Europe | Products
22 Feb 2023 by Marc Wolterink
Ethias has returned to the Belgian market after an absence of 13 years.
Belgium Q4 2022: KBC is back, or are they?
Europe | Products
30 Jan 2023 by SRP News
Sales volumes in the Belgian market reached levels not seen since Q1 2020.
Belgium 9M 2022: FSMA says no to house-indices
Europe | Products
23 Nov 2022 by Marc Wolterink & Nikolay Nikolov
Belgian investors opt for interest-linked structures as the regulator put a stop to complex indices.
Looking back: a ban that changed almost nothing
Europe | Regulations & Legal
29 Sep 2022 by Sybil Yorke
The introduction of a commission ban in the Netherlands almost a decade ago took away ‘perverse incentives’ for intermediaries but the real change came with transparency, disclosure and standardisation.
SRP in brief: finally coming home
International | Industry
12 Jul 2021 by Amélie Labbe
As the UK licks its Euro 2020 football (soccer) wounds, the structured product market goes from strength to strength on the back of investor interest shifting to these products.
FSMA bans 12 structured products, detects KID shortcomings
Europe | Regulations & Legal
29 Jun 2021 by SRP News
The Belgian regulator deemed 12 structured products linked to proprietary indices ‘too complex’ for retail investors in 2020.